Luca Ausili Cefaro

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex^®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

Alena Novotná, Jan Mareš, S. Ratcliffe et al. · European Journal of Neurology · 2011 · 464 citations

Medicine, Neurology, Pharmacology +17

Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study

Emilia Sbardella, Valentina Tomassini, Claudio Gasperini et al. · BMC Neurology · 2009 · 29 citations · Full text

Life Sciences, Immunology, Neurology +14

Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course

Emilia Sbardella, Anita Greco, Maria Laura Stromillo et al. · Multiple Sclerosis Journal · 2012 · 25 citations

Life Sciences, Neurology, Neuroscience +17

Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis

Emilia Sbardella, Valentina Tomassini, ML Stromillo et al. · Multiple Sclerosis Journal · 2011 · 22 citations

Medicine, Neurology, Radiology +17

Neuro-Oncology Multidisciplinary Tumor Board: The Point of View of the Neuroradiologist

Simona Gaudino, Carolina Giordano, Francesca Magnani et al. · Journal of Personalized Medicine · 2022 · 22 citations · Full text

Medicine, Oncology, Radiation Oncology +11